ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Keros Therapeutics Inc

Keros Therapeutics Inc (KROS)

17.03
0.11
(0.65%)
終了 12月22日 6:00AM
17.01
-0.02
(-0.12%)
取引時間後: 9:23AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
17.01
買値
16.23
売値
18.20
出来高
1,469,551
16.62 日の範囲 17.6381
15.67 52 週間の範囲 73.00
時価総額
前日終値
16.92
始値
16.77
最終取引時間
財務取引量
US$ 25,050,575
VWAP
17.0464
平均取引量 (3 か月)
809,234
発行済株式数
40,507,409
配当利回り
-
PER
-4.52
1 株当たり利益 (EPS)
-3.78
歳入
151k
純利益
-152.99M

Keros Therapeutics Inc について

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candida... Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Dover, Delaware, USA
設立
-
Keros Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker KROS. The last closing price for Keros Therapeutics was US$16.92. Over the last year, Keros Therapeutics shares have traded in a share price range of US$ 15.67 to US$ 73.00.

Keros Therapeutics currently has 40,507,409 shares in issue. The market capitalisation of Keros Therapeutics is US$685.39 million. Keros Therapeutics has a price to earnings ratio (PE ratio) of -4.52.

KROS 最新ニュース

Keros Therapeutics Announces Update on the Phase 2 TROPOS Trial

Keros will host an update call and webcast today, December 12, 2024, at 8:00 a.m. ET LEXINGTON, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”...

Keros Therapeutics Presents Clinical Data from its Elritercept Program at the 66th American Society of Hematology Annual Meeting and Exposition

Elritercept demonstrated a durable transfusion independence in lower-risk myelodysplastic syndromes, including in patients with high transfusion burden, with a median duration of response of 134.1...

Keros Therapeutics Announces Global License Agreement with Takeda to Advance Elritercept

Keros Therapeutics to receive upfront payment of $200 million and is eligible to receive development, approval and commercial milestone payments with the potential to exceed $1.1 billion and...

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

LEXINGTON, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-1.98-10.426540284418.9921.0516.305264432318.27620761CS
4-36.66-68.306316377953.6772.3715.67175164625.94814116CS
12-40.3-70.319316000757.3172.3715.6780923436.3910117CS
26-27.17-61.498415572744.1872.3715.6757059840.86787132CS
52-17.33-50.465928945834.347315.6747626846.69956606CS
156-33.4-66.256695100250.417315.6729828844.14027807CS
260-3.09-15.373134328420.188.815.6724147245.67559138CS

KROS - Frequently Asked Questions (FAQ)

What is the current Keros Therapeutics share price?
The current share price of Keros Therapeutics is US$ 17.01
How many Keros Therapeutics shares are in issue?
Keros Therapeutics has 40,507,409 shares in issue
What is the market cap of Keros Therapeutics?
The market capitalisation of Keros Therapeutics is USD 685.39M
What is the 1 year trading range for Keros Therapeutics share price?
Keros Therapeutics has traded in the range of US$ 15.67 to US$ 73.00 during the past year
What is the PE ratio of Keros Therapeutics?
The price to earnings ratio of Keros Therapeutics is -4.52
What is the cash to sales ratio of Keros Therapeutics?
The cash to sales ratio of Keros Therapeutics is 4.62k
What is the reporting currency for Keros Therapeutics?
Keros Therapeutics reports financial results in USD
What is the latest annual turnover for Keros Therapeutics?
The latest annual turnover of Keros Therapeutics is USD 151k
What is the latest annual profit for Keros Therapeutics?
The latest annual profit of Keros Therapeutics is USD -152.99M
What is the registered address of Keros Therapeutics?
The registered address for Keros Therapeutics is 850 NEW BURTON ROAD, SUITE 201, DOVER, DELAWARE, 19904
What is the Keros Therapeutics website address?
The website address for Keros Therapeutics is www.kerostx.com
Which industry sector does Keros Therapeutics operate in?
Keros Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MYSZMy Size Inc
US$ 4.2001
(211.12%)
120.01M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
76.64M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
33.95M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.61k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
120.4M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.5M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.63M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.84M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
8.58M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
5.96M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.32M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
305.1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
292.16M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
287.21M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
277.63M

最近閲覧した銘柄

Delayed Upgrade Clock